Cytokinetics, Incorporated
CYTK
$38.34
$0.290.76%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -134.37M | -161.38M | -150.02M | -160.55M | -143.32M |
| Total Depreciation and Amortization | 2.29M | 2.30M | 2.38M | 2.41M | 2.41M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 54.96M | 32.66M | 40.35M | 46.75M | 31.83M |
| Change in Net Operating Assets | -51.11M | -5.20M | 41.71M | 9.88M | 9.77M |
| Cash from Operations | -128.24M | -131.62M | -65.57M | -101.50M | -99.31M |
| Capital Expenditure | -4.15M | -5.66M | -1.29M | -701.00K | -1.92M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 57.03M | 111.62M | 112.15M | -44.35M | -649.63M |
| Cash from Investing | 52.88M | 105.96M | 110.86M | -45.05M | -651.55M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.70M | -2.88M | -2.91M | -2.89M | -2.88M |
| Issuance of Common Stock | 6.75M | 7.65M | 6.48M | 6.32M | 623.89M |
| Repurchase of Common Stock | -514.00K | -13.00K | -1.18M | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 75.00M | -- | 0.00 | 0.00 | 200.00M |
| Cash from Financing | 78.53M | 4.75M | 2.38M | 3.43M | 821.01M |
| Foreign Exchange rate Adjustments | -682.00K | -270.00K | 292.00K | -126.00K | 16.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.50M | -21.18M | 47.97M | -143.25M | 70.17M |